NIH director nominee Jay Bhattacharya faces Senate confirmation hearing
Jay Bhattacharya's Confirmation Hearing Proves the Lockdown Skeptics Won
What Jay Bhattacharya's Confirmation Hearing Taught Us About Trump's Pick for NIH Director
Trump’s pick to lead FDA tells senators he’d look into food, abortion pill, vaccine advisers
President Donald Trump’s pick to lead the US Food and Drug Administration told senators in a tense confirmation hearing Thursday that, if confirmed as FDA commissioner, he plans to evaluate school lunches,
Science-Based Medicine3h
Paul Thacker relitigates criticisms of Dr. Jay Bhattacharya and the Great Barrington Declaration
"Journalist" Paul Thacker defends Dr. Jay Bhattacharya and the Great Barrington Declaration by rehashing the same old deceptive rhetoric that was easily debunked when it was first employed.
Guarded N.I.H. Nominee Faces Sharp Questions on Vaccines and Research Cuts
Jay Bhattacharya, a health economist, gained prominence during the Covid pandemic when he argued against lockdowns.
IndiaWest5h
Jay Bhattacharya Supports Childhood Vaccinations, Even Measles
WASHINGTON, DC – Dr. Jay Bhattacharya, the nominee to lead the National Institutes of Health (NIH), pledged to prioritize chronic diseases, enhance research integrity, and foster scientific debate during his Senate confirmation hearing.
STAT2d
‘Wrong,’ ‘misleading,’ and ‘reasonable’: How Jay Bhattacharya became, for some, the least bad option to run NIH
Judges criticized Jay Bhattacharya's expert witness testimony as untrustworthy, but a Stanford colleague described him as a "reasonable person, not an ideologue"
STAT1d
Bhattacharya demurs on his view on Trump’s slashing of NIH indirect costs
President Trump's nominee to lead the NIH, Jay Bhattacharya, demurred on his view on Trump’s move to slashi NIH indirect cost payments to universities and other instituions.
Nature23h
Trump's nominee for NIH chief talks frozen grants and fostering ‘scientific dissent’
Health economist Jay Bhattacharya, who drew censure for controversial views on COVID-19, vows to provide funding but is short on details.